West Paces Advisors’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $573K | Buy |
2,596
+75
| +3% | +$20.7K | 0.1% | 94 |
|
|
2026
Q1 | $745K | Buy |
2,521
+60
| +2% | +$17.8K | 0.14% | 78 |
|
|
2025
Q4 | $672K | Sell |
2,461
-2
| -0.1% | -$543 | 0.13% | 79 |
|
|
2025
Q3 | $666K | Sell |
2,463
-20
| -0.8% | -$5.44K | 0.13% | 79 |
|
|
2025
Q2 | $684K | Buy |
2,483
+43
| +2% | +$11.7K | 0.15% | 71 |
|
|
2025
Q1 | $647K | Buy |
2,440
+105
| +4% | +$25.9K | 0.15% | 72 |
|
|
2024
Q4 | $542K | Buy |
2,335
+28
| +1% | +$6.44K | 0.13% | 74 |
|
|
2024
Q3 | $509K | Buy |
2,307
+66
| +3% | +$13.7K | 0.12% | 81 |
|
|
2024
Q2 | $441K | Buy |
2,241
+115
| +5% | +$23.8K | 0.11% | 87 |
|
|
2024
Q1 | $458K | Buy |
2,126
+1,400
| +193% | +$294K | 0.12% | 83 |
|
|
2023
Q4 | $153K | Buy |
726
+48
| +7% | +$10.2K | 0.04% | 142 |
|
|
2023
Q3 | $136K | Hold |
678
| – | – | 0.04% | 140 |
|
|
2023
Q2 | $126K | Hold |
678
| – | – | 0.04% | 159 |
|
|
2023
Q1 | $130K | Hold |
678
| – | – | 0.04% | 147 |
|
|
2022
Q4 | $114K | Hold |
678
| – | – | 0.04% | 153 |
|
|
2022
Q3 | $120K | Hold |
678
| – | – | 0.04% | 151 |
|
|
2022
Q2 | $139K | Sell |
678
-125
| -16% | -$26.5K | 0.05% | 140 |
|
|
2022
Q1 | $191K | Hold |
803
| – | – | 0.06% | 129 |
|
|
2021
Q4 | $183K | Sell |
803
-214
| -21% | -$47.1K | 0.06% | 128 |
|
|
2021
Q3 | $197K | Hold |
1,017
| – | – | 0.07% | 112 |
|
|
2021
Q2 | $216K | Hold |
1,017
| – | – | 0.08% | 107 |
|
|
2021
Q1 | $208K | Hold |
1,017
| – | – | 0.08% | 106 |
|
|
2020
Q4 | $185K | Hold |
1,017
| – | – | 0.08% | 106 |
|
|
2020
Q3 | $170K | Sell |
1,017
-143
| -12% | -$24.1K | 0.09% | 110 |
|
|
2020
Q2 | $189K | Hold |
1,160
| – | – | 0.1% | 102 |
|
|
2020
Q1 | $201K | Hold |
1,160
| – | – | 0.13% | 98 |
|
|
2019
Q4 | $233K | Buy |
1,160
+137
| +13% | +$28.1K | 0.13% | 100 |
|
|
2019
Q3 | $216K | Hold |
1,023
| – | – | 0.13% | 102 |
|
|
2019
Q2 | $199K | Hold |
1,023
| – | – | 0.12% | 103 |
|
|
2019
Q1 | $168K | Hold |
1,023
| – | – | 0.12% | 107 |
|
|
2018
Q4 | $192K | Hold |
1,023
| – | – | 0.15% | 103 |
|
|
2018
Q3 | $174K | Hold |
1,023
| – | – | 0.13% | 110 |
|
|
2018
Q2 | $168K | Hold |
1,023
| – | – | 0.13% | 109 |
|
|
2018
Q1 | $165K | Sell |
1,023
-28
| -3% | -$4.46K | 0.12% | 110 |
|
|
2017
Q4 | $153K | Sell |
1,051
-22
| -2% | -$3.13K | 0.11% | 114 |
|
|
2017
Q3 | $146K | Hold |
1,073
| – | – | 0.11% | 118 |
|
|
2017
Q2 | $134K | Hold |
1,073
| – | – | 0.11% | 123 |
|
|
2017
Q1 | $127K | Hold |
1,073
| – | – | 0.1% | 126 |
|
|
2016
Q4 | $124K | Buy |
+1,073
| New | +$119K | 0.12% | 133 |
|
Other funds holding CME
West Paces Advisors's CME Position: Q2 2026 in Review
West Paces Advisors increased its CME Group (CME) stake by 3% in Q2 2026, buying an estimated $20.7K and bringing the position to 2,596 shares worth $573K. The position accounts for 0.1% of the portfolio, ranked #94.
West Paces Advisors first reported a position in CME in Q4 2016 and has held it in 39 quarters since. The position peaked at $745K in Q1 2026. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- West Paces Advisors held 2,596 shares of CME Group worth $573K as of Q2 2026.
- West Paces Advisors bought 75 CME Group shares in Q2 2026, an estimated $20.7K.
- CME Group made up 0.1% of West Paces Advisors's portfolio in Q2 2026, its #94 holding.
- West Paces Advisors first reported a position in CME Group in Q4 2016 and has held it in 39 quarters since.
- West Paces Advisors's CME Group position peaked at $745K in Q1 2026.
- 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on West Paces Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.